Chile · Delayed Price · Currency is CLP Coca-Cola Embonor Statistics
Total Valuation
SNSE:EMBONOR.A has a market cap or net worth of CLP 786.01 billion. The enterprise value is 988.29 billion.
| Market Cap | 786.01B |
| Enterprise Value | 988.29B |
Important Dates
The next estimated earnings date is Friday, October 30, 2026.
| Earnings Date | Oct 30, 2026 |
| Ex-Dividend Date | May 14, 2026 |
Share Statistics
SNSE:EMBONOR.A has 510.85 million shares outstanding.
| Current Share Class | 244.42M |
| Shares Outstanding | 510.85M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 9.28% |
| Float | 209.25M |
Valuation Ratios
The trailing PE ratio is 7.76.
| PE Ratio | 7.76 |
| Forward PE | n/a |
| PS Ratio | 0.60 |
| PB Ratio | 1.27 |
| P/TBV Ratio | 1.67 |
| P/FCF Ratio | 6.87 |
| P/OCF Ratio | 4.88 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.29, with an EV/FCF ratio of 8.64.
| EV / Earnings | 11.28 |
| EV / Sales | 0.76 |
| EV / EBITDA | 5.29 |
| EV / EBIT | 7.77 |
| EV / FCF | 8.64 |
Financial Position
The company has a current ratio of 1.99, with a Debt / Equity ratio of 0.62.
| Current Ratio | 1.99 |
| Quick Ratio | 1.34 |
| Debt / Equity | 0.62 |
| Debt / EBITDA | 2.09 |
| Debt / FCF | 3.37 |
| Interest Coverage | 6.50 |
Financial Efficiency
Return on equity (ROE) is 14.71% and return on invested capital (ROIC) is 12.27%.
| Return on Equity (ROE) | 14.71% |
| Return on Assets (ROA) | 6.48% |
| Return on Invested Capital (ROIC) | 12.27% |
| Return on Capital Employed (ROCE) | 12.72% |
| Weighted Average Cost of Capital (WACC) | 4.26% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.08 |
| Inventory Turnover | 5.70 |
Taxes
In the past 12 months, SNSE:EMBONOR.A has paid 22.42 billion in taxes.
| Income Tax | 22.42B |
| Effective Tax Rate | 20.38% |
Stock Price Statistics
| Beta (5Y) | 0.03 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 1,330.00 |
| 200-Day Moving Average | 1,330.00 |
| Relative Strength Index (RSI) | 100.00 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SNSE:EMBONOR.A had revenue of CLP 1.30 trillion and earned 87.58 billion in profits. Earnings per share was 171.44.
| Revenue | 1.30T |
| Gross Profit | 494.86B |
| Operating Income | 125.15B |
| Pretax Income | 110.01B |
| Net Income | 87.58B |
| EBITDA | 181.43B |
| EBIT | 125.15B |
| Earnings Per Share (EPS) | 171.44 |
Balance Sheet
The company has 183.11 billion in cash and 385.36 billion in debt, with a net cash position of -202.25 billion or -395.90 per share.
| Cash & Cash Equivalents | 183.11B |
| Total Debt | 385.36B |
| Net Cash | -202.25B |
| Net Cash Per Share | -395.90 |
| Equity (Book Value) | 619.03B |
| Book Value Per Share | 1,211.69 |
| Working Capital | 213.98B |
Cash Flow
In the last 12 months, operating cash flow was 161.13 billion and capital expenditures -46.69 billion, giving a free cash flow of 114.44 billion.
| Operating Cash Flow | 161.13B |
| Capital Expenditures | -46.69B |
| Depreciation & Amortization | 56.28B |
| Net Borrowing | 3.30B |
| Free Cash Flow | 114.44B |
| FCF Per Share | 224.03 |
Margins
Gross margin is 38.06%, with operating and profit margins of 9.63% and 6.74%.
| Gross Margin | 38.06% |
| Operating Margin | 9.63% |
| Pretax Margin | 8.46% |
| Profit Margin | 6.74% |
| EBITDA Margin | 13.96% |
| EBIT Margin | 9.63% |
| FCF Margin | 8.80% |
Dividends & Yields
This stock pays an annual dividend of 84.76, which amounts to a dividend yield of 6.37%.
| Dividend Per Share | 84.76 |
| Dividend Yield | 6.37% |
| Dividend Growth (YoY) | 3.49% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 50.73% |
| Buyback Yield | n/a |
| Shareholder Yield | 6.37% |
| Earnings Yield | 11.14% |
| FCF Yield | 14.56% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SNSE:EMBONOR.A has an Altman Z-Score of 2.84 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.84 |
| Piotroski F-Score | 7 |